Survival and multi-omics analysis of immunotherapy-based conversion treatment for initially unresectable gastric cancer
ICIs-based conversion therapy demonstrates promising survival benefits and manageable safety profiles for patients with unresectable locally advanced or oligometastatic gastric cancer, and provides real-world evidence for a potential treatment strategy. Additionally, multi-omics findings have revealed drug resistance mechanisms and potential biomarkers of efficacy.
Authors
- Xiaohan Cui
- Xin Dai
- Qian Xu
- Wen Zhao
- Lian Liu
- Song Li
- Zhaodi Nan
- Duanbo Shi
- Di Zhang
- Zimin Liu
- Shulun Nie
- Shuang Wang
- Wenbin Yu
- Meng Wei
- Xinyu Song
Institutions
- Qingdao University (CN)
- Shandong University of Traditional Chinese Medicine (CN)
- Jining Traditional Chinese Medicine Hospital (CN)
- Shandong Provincial Hospital (CN)
- Affiliated Hospital of Qingdao University (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.3389/fimmu.2025.1753749
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China